People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Abgenomics International Inc | — | Biotechnology | Series B | $46.4M | $522.3M | 2013 |
Yu-Chuan Yan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Yu-Chuan Yan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kim Graham | 1 | 1 |
| Yung-Hua Chung | 1 | 1 |
| Nai-Yu Pai | 1 | 1 |
| Stephen Polmar | 1 | 1 |
| Rong Hwa Lim | 1 | 1 |
| Yu-Chuan Yang | 1 | 1 |
| Rong Hwa Lin | 1 | 1 |
| Chih Shan Li | 1 | 1 |
| Chia-Jung Yang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.